Invesco's reduction below 5% adds to a pattern of institutional exits from Collegium, with three major filers (Vanguard, Principal, Invesco) all reporting sub-5% stakes in recent weeks. Monitor next 13F filing for full position details and watch for any further institutional selling pressure.
COLL drugs
COLL drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 10 $24.47entry
- T+1 · 6d ago +1.39%α +0.07% · $24.81
- T+4 · todayOpen
- T+5 · in 4h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Invesco Ltd. filed an amended Schedule 13G disclosing a 3.9% passive stake in Collegium Pharmaceutical as of September 30, 2026, down from a prior 5%+ position. The filing indicates Invesco reduced its holdings below the 5% threshold, continuing a pattern of institutional exits from Collegium.
Key Financial Metrics
Key Facts
- Invesco Ltd. filed an amended Schedule 13G disclosing beneficial ownership of 1,261,037 shares of Collegium Pharmaceutical common stock as of September 30, 2026.
- The stake represents 3.9% of shares outstanding, down from a prior 5%+ position.
- This is the third institutional filer in recent weeks to report a stake below 5% (following Vanguard and Principal Global Investors).
- The filing was made under Rule 13d-1(b), confirming passive intent.
Financial Impact
Invesco reduced its stake from above 5% to 3.9%, representing a reduction of at least 1.1% of shares outstanding (approximately 355,000+ shares based on prior 5% threshold).
Risk Factors
- Continued institutional selling pressure as multiple large holders reduce positions
- Potential for additional passive holders to exit below 5% threshold
- Reduced institutional support may weigh on stock liquidity and valuation
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000914208-26-000400 |
| Document: 0000914208-26-000400-index.html | 0000914208-26-000400 |
| Document: 0000914208-26-000400.txt | 0000914208-26-000400 |
Track record
24 reports on COLL
1 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +0.28% at T+1 after the Aug 13, 2026 report. 1 of 5 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $25.68 Now $25.43 −0.97% settles Nov 17
- Nov 10, 20266d ago SC 13G/A Bearish 4/10 Viewing Entry $24.47 to $24.81 Now $25.43 −3.92% ▼ −1.39% −0.07% vs SPY
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $24.47 to $24.81 Now $25.43 +3.92% ▲ +1.39% +0.07% vs SPY
- Nov 9, 20267d ago Institutional Cluster Bearish 4/10 Entry $24.47 to $24.81 Now $25.43 −3.92% ▼ −1.39% −0.07% vs SPY
- Nov 5, 202611d ago 8-K Neutral 5/10 No price data
- Nov 5, 202611d ago Press Release Neutral 5/10 Entry $25.16 to $24.21 Now $25.43 +1.07% ▼ −3.78% −4.09% vs SPY
- Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $23.80 to $23.68 Now $25.43 +6.85% ▼ −0.50% −0.03% vs SPY
- Oct 29, 202618d ago SC 13G/A Neutral 3/10 Entry $24.03 to $23.80 Now $25.43 +5.83% ▼ −0.96% +0.82% vs SPY
- Oct 29, 202618d ago Press Release Neutral 2/10 Entry $24.03 to $23.80 Now $25.43 +5.83% ▼ −0.96% +0.82% vs SPY
- Oct 22, 202625d ago Press Release Neutral 1/10 Entry $23.50 to $22.96 Now $25.43 +8.21% ▼ −2.30% −1.78% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers